Centro de Investigación Biomédica en Red de Salud Mental
24
2
2
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 24 trials
100.0%
+13.5% vs industry average
33%
8 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (24)
Preventing Suicide With Digital Phenotyping and Pharmacogenetics-Based Interventions
Role: collaborator
Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders
Role: collaborator
EMDR vs Supportive Therapy in Relapse Prevention in Traumatized Bipolar Patients
Role: collaborator
Randomised Clinical Trial to Evaluate the Efficacy of an Online Cognitive Rehabilitation Programme (COPERIA-COG) for Patients With Persistent COVID-19
Role: collaborator
Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIP
Role: collaborator
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients
Role: collaborator
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up
Role: collaborator
Impact of Aerobic Exercise on Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Mental Disorders
Role: collaborator
Cost-effectiveness of Interventions in First-episode Psychosis
Role: collaborator
Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia
Role: collaborator
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
Role: collaborator
10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
Role: collaborator
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up
Role: collaborator
Self-Monitoring and Psychoeducation in Bipolar Patients With a Smart-phone Application
Role: collaborator
Cognitive Remediation Therapy (CRT) in Adolescents With EOS
Role: collaborator
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
Role: collaborator
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis
Role: collaborator
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up
Role: collaborator
3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
Role: collaborator
Effects of Cognitive Remediation Therapy on Schizophrenia Patients Through Functional Magnetic Resonance Imaging
Role: collaborator